Prevention of metastatic spread by postoperative immunotherapy with virally modified autologous tumor cells. I. Parameters for optimal therapeutic effects

Lymphoma cell-mediated degradation of sulfated proteoglycans in the subendothelial extracellular matrix: relationship to tumor cell metastasis.

1983 • 259 citations

Newcastle disease virus as an antineoplastic agent

1965 • 214 citations

A phase II study on the postsurgical management of stage II malignant melanoma with a Newcastle disease virus oncolysate

1983 • 171 citations

Antigenic variation of Newcastle disease virus strains detected by monoclonal antibodies

1983 • 168 citations

The Murine Antitumor Immune Response and Its Therapeutic Manipulation

1984 • 164 citations

Tumor metastases and cell‐mediated immunity in a model system in DBA/2 mice. I. Tumor invasiveness in vitro and metastasis formation in vivo

1979 • 159 citations

Studies on the assembly of the envelope of Newcastle disease virus

1976 • 145 citations

Regulatory Mechanisms in the Immune Response to Cell-surface Antigens

1977 • 118 citations

Tumor metastases and cell‐mediated immunity in a model system in DBA/2 mice.: Iv. Antigenic differences between a metastasizing variant and the parental tumor line revealed by cytotoxic T lymphocytes

1979 • 115 citations

Response of Syngeneic Murine Lymphomata to Immunotherapy in Relation to the Antigenicity of the Tumour

1972 • 99 citations

Antigenic variation in cancer metastasis: immune escape versus immune control

1982 • 95 citations

Tumour Immunity induced in Mice with Cell-free Homogenates of Influenza Virus-infected Tumour Cells

1971 • 94 citations

Newcastle disease virus pathotypes

1974 • 90 citations

Viral Xenogenization of Intact Tumor Cells

1979 • 71 citations

Viruses as immunological adjuvants in cancer

1974 • 68 citations

Virus Augmentation of The Antigenicity of Tumor Cell

1979 • 64 citations

Inhibition of Transplanted Rat Tumors by Immunization With Identical Tumor Cells Infected With Friend Virus

1970 • 62 citations

Tumor metastases and cell‐mediated immunity in a model system in DBA/2 mice. VI. Similar specificity patterns of protective anti‐tumor immunity in vivo and of cytolytic T cells in vitro

1979 • 58 citations

Viral oncolysate in the management of malignant melanoma.I. Preparation of the oncolysate and measurement of immunologic responses

1977 • 53 citations

The structural polypeptides of avian paramyxoviruses

1981 • 52 citations

Virus‐augmented tumor transplantation antigens: Evidence for a helper antigen mechanism

1974 • 51 citations

A microwell immunoperoxidase test for screening hybridomas and for diagnosing newcastle disease virus and sendai virus

1983 • 50 citations

Different expression of Lyt differentiation antigens and cell surface glycoproteins by a murine T lymphoma line and its highly metastatic variant

1982 • 49 citations

Natural killer cell cytotoxic potential of patients with ovarian carcinoma and its modulation with virus-modified tumor cell extract

1984 • 36 citations

Studies on Interferon Production and Interferon Sensitivity of Different Strains of Newcastle Disease Virus

1973 • 31 citations

Release of discrete interferons by cytotoxic T lymphocytes in response to immune and nonimmune stimuli.

1984 • 29 citations

Relationship between enhanced macrophage phagocytic activity and the induction of interferon by Newcastle disease virus in mice.

1980 • 23 citations

<italic>Brief Communication:</italic> Inhibition of Metastasis in Rats Immunized With Xenogenized Autologous Tumor Cells After Excision of the Primary Tumor<xref ref-type="fn" rid="fn2">2</xref>

1975 • 23 citations

Selective antimetastatic drugs (review).

1981 • 23 citations

CLINICAL STUDIES EMPLOYING INTERFERON INDUCERS IN MAN AND ANIMALS *

1970 • 23 citations

Interferon Production in Mouse Spleen Cells and Mouse Fibroblasts (L Cells) Stimulated by Various Strains of Newcastle Disease Virus

1982 • 22 citations

Immune responses in mice to tumour challenge after immunization with newcastle disease virus-infected or X-irradiated tumour cells or cell fractions

1973 • 22 citations

Increased or decreased immunogenicity of tumor-associated antigen according to the amount of virus-associated antigen in rat tumor cells infected with friend virus

1982 • 22 citations

Tumor metastases and cell‐mediated immunity in a model system in DBA/2 mice. V. Transfer of protective immunity with H‐2 identical immune T cells from B10.D2 mice

1979 • 21 citations

Immunogenicity of oncolysates obtained from Ehrlich ascites tumors infected with vesicular stomatitis virus

1970 • 19 citations

Protection of mice against cancer by immunization with membranes but not purified virions from virus infected cancer cells

1975 • 14 citations

Immunotherapy for vulvar carcinoma with virus-modified homologous extracts.

1983 • 14 citations

AUGMENTATION OF HUMAN NATURAL KILLER CELLS WITH HUMAN LEUKOCYTE AND HUMAN RECOMBINANT LEUKOCYTE INTERFERON

1982 • 10 citations

Virus-augmented delayed hypersensitivity skin tests in gynecological malignancies

1984 • 6 citations

Infektionskrankheiten

2006 • 4 citations